405 related articles for article (PubMed ID: 16032704)
41. The role of Helicobacter pylori CagA in gastric carcinogenesis.
Hatakeyama M
Int J Hematol; 2006 Nov; 84(4):301-8. PubMed ID: 17118755
[TBL] [Abstract][Full Text] [Related]
42. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
[TBL] [Abstract][Full Text] [Related]
43. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.
Kikuchi S; Crabtree JE; Forman D; Kurosawa M
Am J Gastroenterol; 1999 Dec; 94(12):3455-9. PubMed ID: 10606302
[TBL] [Abstract][Full Text] [Related]
44. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
[TBL] [Abstract][Full Text] [Related]
45. [Genotyping of Helicobacter pylori virulence factors vacA and cagA in individuals from two regions in Colombia with opposing risk for gastric cancer].
Trujillo E; Martínez T; Bravo MM
Biomedica; 2014; 34(4):567-73. PubMed ID: 25504245
[TBL] [Abstract][Full Text] [Related]
46. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
47. Oncogenic mechanisms of the Helicobacter pylori CagA protein.
Hatakeyama M
Nat Rev Cancer; 2004 Sep; 4(9):688-94. PubMed ID: 15343275
[TBL] [Abstract][Full Text] [Related]
48. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico.
Torres J; Pérez-Pérez GI; Leal-Herrera Y; Muñoz O
Int J Cancer; 1998 Oct; 78(3):298-300. PubMed ID: 9766561
[TBL] [Abstract][Full Text] [Related]
49. Helicobacter pylori infection in two areas in Japan with different risks for gastric cancer.
Nobuta A; Asaka M; Sugiyama T; Kato M; Hige S; Takeda H; Kato T; Ogoshi K; Keida Y; Shinomura J
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():1-6. PubMed ID: 15298598
[TBL] [Abstract][Full Text] [Related]
50. Serum pepsinogen II is a better diagnostic marker in gastric cancer.
Cao XY; Jia ZF; Jin MS; Cao DH; Kong F; Suo J; Jiang J
World J Gastroenterol; 2012 Dec; 18(48):7357-61. PubMed ID: 23326145
[TBL] [Abstract][Full Text] [Related]
51. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
52. PGC TagSNP and its interaction with H. pylori and relation with gene expression in susceptibility to gastric carcinogenesis.
He CY; Sun LP; Xu Q; Liu JW; Jiang JY; Dong NN; Yuan Y
PLoS One; 2014; 9(12):e115955. PubMed ID: 25551587
[TBL] [Abstract][Full Text] [Related]
53. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.
Di Mario F; Moussa AM; Caruana P; Merli R; Cavallaro LG; Cavestro GM; Dal Bò N; Iori V; Pilotto A; Leandro G; Franzè A; Rugge M
Scand J Gastroenterol; 2003 Dec; 38(12):1223-7. PubMed ID: 14750641
[TBL] [Abstract][Full Text] [Related]
54. Meta-analysis of the association between PTPN11 G/A polymorphism at intron 3 with risk of gastric atrophy among East Asians.
Pabalan N; Singh N; Pineda MR; Jarjanazi H
J Gastrointest Cancer; 2014 Sep; 45(3):319-24. PubMed ID: 24706100
[TBL] [Abstract][Full Text] [Related]
55. Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.
Shiota S; Murakami K; Okimoto T; Kodama M; Yamaoka Y
J Gastroenterol Hepatol; 2014 Jan; 29(1):67-73. PubMed ID: 24033876
[TBL] [Abstract][Full Text] [Related]
56. Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group.
Webb PM; Crabtree JE; Forman D
Gastroenterology; 1999 Feb; 116(2):269-76. PubMed ID: 9922306
[TBL] [Abstract][Full Text] [Related]
57. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
58. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
59. Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese.
He C; Tu H; Sun L; Xu Q; Li P; Gong Y; Dong N; Yuan Y
Carcinogenesis; 2013 Jul; 34(7):1450-7. PubMed ID: 23455381
[TBL] [Abstract][Full Text] [Related]
60. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
